Advertisement

Drug Safety in Some Common Medical Conditions

  • Peter I. Folb

Abstract

The drug treatment of congestive cardiac failure is shown diagrammatically in Fig. 2.1. Most patients are effectively managed with diuretics and digitalis, and vasodilator agents have become an accepted second-line approach for patients who do not respond to standard therapy.

Keywords

Uric Acid Lactic Acidosis Nalidixic Acid Cerebral Malaria Congestive Cardiac Failure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Further Reading

  1. Adler S (1974) Methyldopa-irtduced decrease in mental activity. JAMA 230:1428PubMedCrossRefGoogle Scholar
  2. Colucci WS (1982) Prazosin review. Ann Intern Med 97:67PubMedGoogle Scholar
  3. Editorial (1975) Side effects of methyldopa. Br Med J I:646Google Scholar
  4. Editorial (1980) Minoxidil. Med Lett Drugs Ther 22:21Google Scholar
  5. Editorial (1980) Captopril. Lancet II:129Google Scholar
  6. Food and Drug Administration Drug Bulletin (1981) Captopril. 11:10Google Scholar
  7. Hoorntje SJ et al. (1980) Immune complex glomerulopathy with captopril. Lancet I:1212CrossRefGoogle Scholar
  8. Linas SL Niles AS (1981) Minoxidil. Ann Intern Med. 94:61PubMedGoogle Scholar
  9. Medical Letter on Drugs and Therapeutics (1972) Drugs in hypertension. 14:63Google Scholar
  10. Mitchell HC et al. (1980) Renal function during long-term treatment of hypertension with minoxidil. Ann Intern Med 93:676PubMedGoogle Scholar

Further Reading

  1. British National Formulary (1981) No 2. British Medical Association and The Pharmaceutical Society of Great Britain, London, p 94Google Scholar
  2. Hughes DT (1978) Cough suppressants. Br Med J I:1202CrossRefGoogle Scholar
  3. Irwin RS et al. (1977) Review of cough. Arch Intern Med 137:1186PubMedCrossRefGoogle Scholar
  4. Ziment I (1978) Respiratory pharmacology and therapeutics. Saunders, PhiladelphiaGoogle Scholar

Further Reading

  1. Editorial (1979) Theophylline in asthma. Drug Ther Bull 17:91Google Scholar
  2. Jacobs ME et al. (1976) Theophylline kinetics. JAMA 235: 1983PubMedCrossRefGoogle Scholar
  3. Rall TW (1980) Theophylline. In: Gilman AG, Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics, 6th ed. Macmillan, New York, p. 592Google Scholar
  4. Ziment I (1978) Respiratory pharmacology and therapeutics. Saunders, PhiladelphiaGoogle Scholar

Further Reading

  1. Girling DJ (1982) Adverse effects of antituberculous drugs. Drugs 23:56PubMedCrossRefGoogle Scholar
  2. Joint Tuberculosis Committee of the British Thoracic and Tuberculosis Association (1973) Chem- oprophylaxis of tuberculosis. Tubercle 54:309CrossRefGoogle Scholar
  3. Kucers A, Bennett NMcK (1979) The use of antibiotics, 3rd edn. Heinemann, LondonGoogle Scholar
  4. Rossouw JE, Saunders SJ (1975) Hepatotoxicity. Q J Med 44:1PubMedGoogle Scholar
  5. Snider DE et al. (1980) Treatment of tuberculosis during pregnancy. Am Rev Respir Dis 122:65PubMedGoogle Scholar

Further Reading

  1. Bruce-Chwatt LJ (1974) Transfusion malaria. Bull WHO 50:337PubMedGoogle Scholar
  2. Hall AP (1976) Quinine-chloroquine interaction. Br Med J I:323CrossRefGoogle Scholar

Further Reading

  1. Bailey RR (1974) Review of UTI. Drugs 8:54PubMedCrossRefGoogle Scholar
  2. Gleckman R et al. (1979) Nalidixic acid. Am J Hosp Pharm 36:1071PubMedGoogle Scholar
  3. Holmberg L et al. (1980) Adverse reactions to nitrofurantoin. Am J Med 69:733PubMedCrossRefGoogle Scholar
  4. Jayasundera NS et al. (1980) Chronic pulmonary reaction to nitrofurantoin. JAMA 243:769PubMedCrossRefGoogle Scholar
  5. Sussman M, Asscher AW (1970) Urinary tract infection. In: Black D, Jones NF (eds) Renal disease, 4th edn. Alden, Oxford, p 400Google Scholar
  6. Yiannikas C et al. (1981) Nitrofurantoin neuropathy. Aust NZ J Med 11:400CrossRefGoogle Scholar

Further Reading

  1. Batist G, Andrews JL (1981) Pulmonary toxicity of antineoplastic drugs. JAMA 246:1449PubMedCrossRefGoogle Scholar
  2. Griffin JD, Garnick MB (1981) Eye toxicity. Cancer 48:1539PubMedCrossRefGoogle Scholar
  3. Praga C et al. (1980) Cardiac toxicity from antitumour therapy. Oncology 37 Suppl 1:51Google Scholar
  4. Rogers HJ et al. (1981) Cancer chemotherapy. In: A textbook of clinical pharmacology. Hodder and Stoughton, London, p 714Google Scholar
  5. Spiegel RJ (1981) Acute toxicities of chemotherapy. Cancer Treat Rev 8:197PubMedCrossRefGoogle Scholar
  6. Thachil JV et al. (1981) Cancer and cancer therapy on fertility. J Urol 126:141PubMedGoogle Scholar

Further Reading

  1. Bothwell TH et al. (eds) (1979) Iron metabolism in man. Oxford, BlackwellGoogle Scholar
  2. British National Formulary (1981) No 2. The British Medical Association and the Pharmaceutical Society of Great Britain, London, p 227Google Scholar
  3. Kerr DNS (1958) Gastrointestinal intolerance to oral iron preparations. Lancet II:489CrossRefGoogle Scholar
  4. Reddy PS, Lewis M (1969) Adverse effects of intravenous iron-dextran in rheumatoid arthritis. Arthritis Rheum 12:454 Further ReadingPubMedCrossRefGoogle Scholar
  5. Barnett AH (1981) Chlorpropamide-alcohol interaction. Br Med J 283:939CrossRefGoogle Scholar
  6. Barnett AH et al. (1980) Insulin treated diabetics given beta-adrenergic blocking agents. Br Med J 280:976PubMedCrossRefGoogle Scholar
  7. Cohen RD (1978) Drugs and lactic acidosis. Adverse Drug Reaction Bull No 70:248CrossRefGoogle Scholar
  8. Editorial (1977) Biguanides, selection. Br Med J IV:1436Google Scholar
  9. Editorial (1980) Diabetic control at night. Lancet II:279Google Scholar
  10. Editorial (1981) Sulphonylurea selection in diabetes mellitus. Drug Ther Bull 19:49Google Scholar
  11. Flier FS et al. (1979) Insulin resistance. N Engl J Med 300:413PubMedCrossRefGoogle Scholar
  12. Gale EAM et al. (1980) In search of the Somogyi effect. Lancet II:279CrossRefGoogle Scholar
  13. Gorden P (1977) Insulin resistance. In: Crepaldi G et al. (eds) Diabetes, obesity and hyperlipide- mias. Academic Press, London, p 128Google Scholar
  14. Kilo C et al. (1980) The Achilles heel of the U.G.D.P. JAMA 243:450CrossRefGoogle Scholar
  15. Kreisberg RA (1980) Lactate homeostasis and lactic acidosis. Ann Intern Med 92:227PubMedGoogle Scholar
  16. Reaven GM (1980) Insulin allergy. In: Podolsky S (ed) Clinical diabetes. Modern management. Appleton Century Crofts, New York, p 114Google Scholar
  17. Reeves WG et al. (1980) Insulin lipoatrophy and lipohypertrophy. Br Med J 280:1500PubMedCrossRefGoogle Scholar
  18. Wright AD (1979) Beta-adrenoreceptor blocking drugs and blood sugar control in diabetes mellitus. Br Med J I:159 Further ReadingCrossRefGoogle Scholar
  19. Baumelou A et al. (1980) Acute renal failure during indomethacin treatment. Acad Rev Calif Acad Periodontol US Sect 9:3611Google Scholar
  20. Flower RJ et al. (1980) Colchicine. In: Gilman AG, Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics, 6th edn. Macmillan, New York, p 718Google Scholar
  21. Lupton GP, Odom RB (1979) Allopurinol hypersensitivity syndrome. J Am Acad Dermatol 1:365PubMedCrossRefGoogle Scholar

Further Reading

  1. Aquilonius SM et al. (1980) Pharmacokinetics and oral bioavailability of pyridostigmine in man. Eur J Clin Pharmacol 18:423PubMedCrossRefGoogle Scholar
  2. Dawkins RL et al. (1981) Myasthenia gravis and D-penicillamine. J Rheumatol 8 [suppl 7]: 169Google Scholar
  3. Lisak RP, Barchi RL (1982) Myasthenia gravis. Saunders, PhiladelphiaGoogle Scholar
  4. Mastaglia FL, Argov Z (1981) Drug-induced neuromuscular disorders in man. In: Walton, Sir John (ed) Disorders of voluntary muscle, 4th edn. Churchill Livingstone, Edinburgh, p 873Google Scholar
  5. Rodat O et al. (1981) D-Penicillamine induced myasthenic syndromes in rheumatoid arthritis. Nouv Presse Med 10:1645PubMedGoogle Scholar
  6. Seybold ME, Drachman DB (1974) Prednisone in myasthenia gravis. N Engl J Med 290:81PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1984

Authors and Affiliations

  • Peter I. Folb
    • 1
    • 2
  1. 1.University of Cape Town Medical SchoolSouth Africa
  2. 2.Groote Schuur HospitalCape TownSouth Africa

Personalised recommendations